Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist (Q36857436)

16 August 2017

Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist (English)

1 reference

16 August 2017

Baron BM

1

1 reference

16 August 2017

Harrison BL

2

1 reference

16 August 2017

Kehne JH

3

1 reference

16 August 2017

Schmidt CJ

4

1 reference

16 August 2017

van Giersbergen PL

5

1 reference

16 August 2017

White HS

6

1 reference

16 August 2017

Siegel BW

7

1 reference

16 August 2017

Senyah Y

8

1 reference

16 August 2017

McCloskey TC

9

1 reference

16 August 2017

Fadayel GM

10

1 reference

16 August 2017

Taylor VL

11

1 reference

16 August 2017

Murawsky MK

12

1 reference

16 August 2017

Nyce P

13

1 reference

16 August 2017

Salituro FG

14

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

European Journal of Pharmacology

16 August 2017

1 reference

16 August 2017

323

1 reference

16 August 2017

2-3

1 reference

16 August 2017

181-192

1 reference

The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Anticonvulsant activity of a novel NMDA/glycine site antagonist, MDL 104,653, against kindled and sound-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Effects of competitive N-methyl-d-aspartate antagonists on midbrain dopamine neurons: An electrophysiological and behavioral comparison to phencyclidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

4-[(Carboxymethyl)oxy]- and 4-[(carboxymethyl)amino]-5,7-dichloroquinoline-2-carboxylic acid: new antagonists of the strychnine-insensitive glycine binding site on the N-methyl-D-aspartate receptor complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Glycine potentiates the NMDA response in cultured mouse brain neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

MDL 27,531 selectively reverses strychnine-induced seizures in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Clinical experience with excitatory amino acid antagonist drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

Effects of competitive and non-competitive N-methyl-D-aspartate (NMDA) antagonists in squirrel monkeys trained to discriminate D-CPPene (SDZ EAA 494) from vehicle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900045-9

10.1016/S0014-2999(97)00045-9

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference